Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

In the latest lawsuit, Apple was awarded $250 in damages – the statutory minimum, which was what the company sought in its ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Apple is fighting a running legal battle with the health tech company Masimo over pulse oximetry technology and smartwatch design patents. A jury in a federal trial awarded Apple a paltry $250 ...

A federal jury has found that Masimo smartwatches infringed on two of Apple's smartwatches, according to media reports.

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in ...

Apple convinced a federal jury on Friday that early versions of health monitoring tech company Masimo's smartwatches infringe ...

Apple and Masimo are back in a California court this week for a bench ... the two companies in which the former alleges the ...

The modular, scalable monitoring platform offers a range of physiological measurements, including Masimo SET ® pulse oximetry, measure-on-inflation noninvasive blood pressure, continuous ...